Lenvatinib Mesylate, 5mg

It is a multi-target tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet-derived growth factor receptor (PDGFR), stem cell factor receptor (KIT), and rearrangement during transfection (RET).

• Size: 5mg
• Purity: ≥98%
• Molecular Formula: C 2 2 H 2 3 ClN 4 O 7 S
• Molecular Weight: 522.96
• Physical State: White to off-white Solid
• Storage: Powder:2-8℃, 2 years
• Brand: Saint Michael
• Catalogue No.: IL2950-5mg

For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.